Cargando…

Validation of mobile eye-tracking as novel and efficient means for differentiating progressive supranuclear palsy from Parkinson's disease

Background: The decreased ability to carry out vertical saccades is a key symptom of Progressive Supranuclear Palsy (PSP). Objective measurement devices can help to reliably detect subtle eye movement disturbances to improve sensitivity and specificity of the clinical diagnosis. The present study ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Marx, Svenja, Respondek, Gesine, Stamelou, Maria, Dowiasch, Stefan, Stoll, Josef, Bremmer, Frank, Oertel, Wolfgang H., Höglinger, Günter U., Einhäuser, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521127/
https://www.ncbi.nlm.nih.gov/pubmed/23248593
http://dx.doi.org/10.3389/fnbeh.2012.00088
_version_ 1782252893910335488
author Marx, Svenja
Respondek, Gesine
Stamelou, Maria
Dowiasch, Stefan
Stoll, Josef
Bremmer, Frank
Oertel, Wolfgang H.
Höglinger, Günter U.
Einhäuser, Wolfgang
author_facet Marx, Svenja
Respondek, Gesine
Stamelou, Maria
Dowiasch, Stefan
Stoll, Josef
Bremmer, Frank
Oertel, Wolfgang H.
Höglinger, Günter U.
Einhäuser, Wolfgang
author_sort Marx, Svenja
collection PubMed
description Background: The decreased ability to carry out vertical saccades is a key symptom of Progressive Supranuclear Palsy (PSP). Objective measurement devices can help to reliably detect subtle eye movement disturbances to improve sensitivity and specificity of the clinical diagnosis. The present study aims at transferring findings from restricted stationary video-oculography (VOG) to a wearable head-mounted device, which can be readily applied in clinical practice. Methods: We investigated the eye movements in 10 possible or probable PSP patients, 11 Parkinson's disease (PD) patients, and 10 age-matched healthy controls (HCs) using a mobile, gaze-driven video camera setup (EyeSeeCam). Ocular movements were analyzed during a standardized fixation protocol and in an unrestricted real-life scenario while walking along a corridor. Results: The EyeSeeCam detected prominent impairment of both saccade velocity and amplitude in PSP patients, differentiating them from PD and HCs. Differences were particularly evident for saccades in the vertical plane, and stronger for saccades than for other eye movements. Differences were more pronounced during the standardized protocol than in the real-life scenario. Conclusions: Combined analysis of saccade velocity and saccade amplitude during the fixation protocol with the EyeSeeCam provides a simple, rapid (<20 s), and reliable tool to differentiate clinically established PSP patients from PD and HCs. As such, our findings prepare the ground for using wearable eye-tracking in patients with uncertain diagnoses.
format Online
Article
Text
id pubmed-3521127
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-35211272012-12-17 Validation of mobile eye-tracking as novel and efficient means for differentiating progressive supranuclear palsy from Parkinson's disease Marx, Svenja Respondek, Gesine Stamelou, Maria Dowiasch, Stefan Stoll, Josef Bremmer, Frank Oertel, Wolfgang H. Höglinger, Günter U. Einhäuser, Wolfgang Front Behav Neurosci Neuroscience Background: The decreased ability to carry out vertical saccades is a key symptom of Progressive Supranuclear Palsy (PSP). Objective measurement devices can help to reliably detect subtle eye movement disturbances to improve sensitivity and specificity of the clinical diagnosis. The present study aims at transferring findings from restricted stationary video-oculography (VOG) to a wearable head-mounted device, which can be readily applied in clinical practice. Methods: We investigated the eye movements in 10 possible or probable PSP patients, 11 Parkinson's disease (PD) patients, and 10 age-matched healthy controls (HCs) using a mobile, gaze-driven video camera setup (EyeSeeCam). Ocular movements were analyzed during a standardized fixation protocol and in an unrestricted real-life scenario while walking along a corridor. Results: The EyeSeeCam detected prominent impairment of both saccade velocity and amplitude in PSP patients, differentiating them from PD and HCs. Differences were particularly evident for saccades in the vertical plane, and stronger for saccades than for other eye movements. Differences were more pronounced during the standardized protocol than in the real-life scenario. Conclusions: Combined analysis of saccade velocity and saccade amplitude during the fixation protocol with the EyeSeeCam provides a simple, rapid (<20 s), and reliable tool to differentiate clinically established PSP patients from PD and HCs. As such, our findings prepare the ground for using wearable eye-tracking in patients with uncertain diagnoses. Frontiers Media S.A. 2012-12-13 /pmc/articles/PMC3521127/ /pubmed/23248593 http://dx.doi.org/10.3389/fnbeh.2012.00088 Text en Copyright © 2012 Marx, Respondek, Stamelou, Dowiasch, Stoll, Bremmer, Oertel, Höglinger and Einhäuser. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc.
spellingShingle Neuroscience
Marx, Svenja
Respondek, Gesine
Stamelou, Maria
Dowiasch, Stefan
Stoll, Josef
Bremmer, Frank
Oertel, Wolfgang H.
Höglinger, Günter U.
Einhäuser, Wolfgang
Validation of mobile eye-tracking as novel and efficient means for differentiating progressive supranuclear palsy from Parkinson's disease
title Validation of mobile eye-tracking as novel and efficient means for differentiating progressive supranuclear palsy from Parkinson's disease
title_full Validation of mobile eye-tracking as novel and efficient means for differentiating progressive supranuclear palsy from Parkinson's disease
title_fullStr Validation of mobile eye-tracking as novel and efficient means for differentiating progressive supranuclear palsy from Parkinson's disease
title_full_unstemmed Validation of mobile eye-tracking as novel and efficient means for differentiating progressive supranuclear palsy from Parkinson's disease
title_short Validation of mobile eye-tracking as novel and efficient means for differentiating progressive supranuclear palsy from Parkinson's disease
title_sort validation of mobile eye-tracking as novel and efficient means for differentiating progressive supranuclear palsy from parkinson's disease
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521127/
https://www.ncbi.nlm.nih.gov/pubmed/23248593
http://dx.doi.org/10.3389/fnbeh.2012.00088
work_keys_str_mv AT marxsvenja validationofmobileeyetrackingasnovelandefficientmeansfordifferentiatingprogressivesupranuclearpalsyfromparkinsonsdisease
AT respondekgesine validationofmobileeyetrackingasnovelandefficientmeansfordifferentiatingprogressivesupranuclearpalsyfromparkinsonsdisease
AT stameloumaria validationofmobileeyetrackingasnovelandefficientmeansfordifferentiatingprogressivesupranuclearpalsyfromparkinsonsdisease
AT dowiaschstefan validationofmobileeyetrackingasnovelandefficientmeansfordifferentiatingprogressivesupranuclearpalsyfromparkinsonsdisease
AT stolljosef validationofmobileeyetrackingasnovelandefficientmeansfordifferentiatingprogressivesupranuclearpalsyfromparkinsonsdisease
AT bremmerfrank validationofmobileeyetrackingasnovelandefficientmeansfordifferentiatingprogressivesupranuclearpalsyfromparkinsonsdisease
AT oertelwolfgangh validationofmobileeyetrackingasnovelandefficientmeansfordifferentiatingprogressivesupranuclearpalsyfromparkinsonsdisease
AT hoglingergunteru validationofmobileeyetrackingasnovelandefficientmeansfordifferentiatingprogressivesupranuclearpalsyfromparkinsonsdisease
AT einhauserwolfgang validationofmobileeyetrackingasnovelandefficientmeansfordifferentiatingprogressivesupranuclearpalsyfromparkinsonsdisease